Profile
Dr. Ian Leitch is a Director-Clinical Research at Opthea Ltd. Dr. Leitch was previously employed as a Senior Manager-Early Development Oncology by Amgen, Inc., a Senior Program Manager-Cardiovascular Research by Miravant Medical Technologies, and a Senior Research Officer by The University of Newcastle.
He received his undergraduate degree from Monash University and a doctorate degree from Monash University.
Ian Leitch active positions
| Companies | Position | Start |
|---|---|---|
| OPTHEA LIMITED | Chief Tech/Sci/R&D Officer | 01/09/2011 |
Former positions of Ian Leitch
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/09/2011 |
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Corporate Officer/Principal | - |
The University of Newcastle
The University of Newcastle Other Consumer ServicesConsumer Services Functions as a College/University | Chief Tech/Sci/R&D Officer | - |
Training of Ian Leitch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Miravant Medical Technologies
Miravant Medical Technologies Pharmaceuticals: MajorHealth Technology Develops light activated drugs and associated devices for photodynamic therapy | Health Technology |
Opthea Ltd.
Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Newcastle
The University of Newcastle Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Ian Leitch
















